Cagrilintide
Cagrilintide
Long-acting amylin analogue investigated in receptor-signalling and metabolic research models.
| Quantity | Discount | Price each |
|---|---|---|
| 2 | 5% | £29.92 |
| 3 | 7% | £29.29 |
| 4+ | 10% | £28.34 |
Research Overview
Cagrilintide is a long-acting amylin analogue investigated in receptor-signalling and metabolic research models.
The 5 mg presentation is supplied as a lyophilized reference material for in vitro laboratory research into peptide signalling and metabolic pathways.
Batch-specific analytical documentation is supplied when available for the relevant lot, covering identity, molecular weight confirmation, and chromatographic assessment.
Technical Specifications
- Lyophilized
- Store −20 °C
Certificate of Analysis
No reviews yet. Be the first to review this product.
Dual-component research blend of CJC-1295 without DAC and Ipamorelin for peptide signalling and receptor-model studies.
Growth hormone releasing peptide (GHRP) analogue investigated in metabolic and recovery research.
Mitochondrial-derived peptide studied in metabolic regulation and exercise-mimetic research.
Sold for in vitro laboratory and research purposes. Not a drug, food, cosmetic, dietary supplement, or medical device. Not for human or animal consumption.